Skip to content

Wound Infusion vs Spinal Morphine for Post-caesarean Analgesia

Is Continuous Wound Infusion With Ropivacaine Better Than Intrathecal Morphine for Post-caesarean Analgesia? A Prospective, Randomized, Controlled, Double Blinded Study

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02264821
Acronym
Apcisaal
Enrollment
192
Registered
2014-10-15
Start date
2012-02-29
Completion date
2014-08-31
Last updated
2015-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Caesarean Analgesia

Keywords

analgesia, caesarean, wound infiltration, intrathecal morphine.

Brief summary

The aim of this study is to compare effective analgesia with continuous wound infiltration of ropivacaine through multi-holed catheter or with morphine 100 mcg added intrathecally to spinal anesthesia, after elective Caesarean delivery.

Detailed description

Double blind, 3 groups * Control group: Rachi 0,1 ml saline, Infusion 300ml saline * Group rachi-morphine: 0,1ml =100µg morphine/300ml saline * Group KT: 0,1 ml saline/300 ml naropin 0.2%

Interventions

wound infiltration

DRUGintrathecal morphine

100 µg added to the spinal anaesthesia

DRUGplacebo

placebo in spinal anaesthesia and in wound infiltration

Sponsors

Dr Madeleine Wilwerth
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 years and more, ASA 1 or ASA 2, pregnant with at least 34 weeks of gestational age, admitted for a planned caesarian with a Pfannenstiel incision and having signed the informed consent form.

Exclusion criteria

* Refusal of the patient or contra-indication to locoregional anesthesia * Allergy to the products used * ASA 3 * ASA 4 * Sleep apnea syndrome and/or obesity (BMI \> 35) * Size inferior to 155cm * existence of a language barrier

Design outcomes

Primary

MeasureTime frameDescription
Duration of Effective Analgesia30 hours after spinal injection T0T0 until first request of morphine PCAIV
Morphine Consumption30 hours after spinal injection T0Morphine consumption with PCAIV

Secondary

MeasureTime frameDescription
Incidence of Morphine Side Effects: Nausea, Vomiting, Pruritus.30 hours after spinal injectionIs there a decrease of the incidence of morphine side effects such as nausea, vomiting, pruritus?

Countries

Belgium

Participant flow

Participants by arm

ArmCount
Ropivacaine Infiltration
ropivacaine 2 mg/ml bolus 15 ml continuous 10 ml/h wound infusion and intrathecal saline ropivacaine infiltration: wound infiltration
63
Rachi Morphine
100 µg intrathecal morphine and saline infiltration intrathecal morphine: 100 µg added to the spinal anaesthesia
61
Placebo
intrathecal saline and saline infiltration placebo: placebo in spinal anaesthesia and in wound infiltration
58
Total182

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyProtocol Violation136

Baseline characteristics

CharacteristicRopivacaine InfiltrationRachi MorphinePlaceboTotal
Age, Continuous30 years32 years32 years32 years
Region of Enrollment
Belgium
63 participants61 participants58 participants182 participants
Sex: Female, Male
Female
63 Participants61 Participants58 Participants182 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
61 / 6361 / 6158 / 58
serious
Total, serious adverse events
0 / 630 / 610 / 58

Outcome results

Primary

Duration of Effective Analgesia

T0 until first request of morphine PCAIV

Time frame: 30 hours after spinal injection T0

ArmMeasureValue (MEDIAN)
Ropivacaine InfiltrationDuration of Effective Analgesia351 minutes
Rachi MorphineDuration of Effective Analgesia380 minutes
PlaceboDuration of Effective Analgesia247 minutes
Primary

Morphine Consumption

Morphine consumption with PCAIV

Time frame: 30 hours after spinal injection T0

ArmMeasureValue (MEDIAN)
Ropivacaine InfiltrationMorphine Consumption8 milligrammes
Rachi MorphineMorphine Consumption4 milligrammes
PlaceboMorphine Consumption20.5 milligrammes
Secondary

Incidence of Morphine Side Effects: Nausea, Vomiting, Pruritus.

Is there a decrease of the incidence of morphine side effects such as nausea, vomiting, pruritus?

Time frame: 30 hours after spinal injection

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026